Indrayani Biotech Ltd
Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
- Market Cap ₹ 193 Cr.
- Current Price ₹ 56.4
- High / Low ₹ 99.7 / 46.8
- Stock P/E 85.4
- Book Value ₹ 15.3
- Dividend Yield 0.00 %
- ROCE 12.5 %
- ROE 17.2 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.69 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding is low: 33.6%
- Tax rate seems low
- Company has a low return on equity of 3.78% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -16.8%
- Working capital days have increased from 110 days to 208 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Hotels & Restaurants Industry: Hotels
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 49.77 | 20.71 | 57.66 | 74.11 | 67.82 | |
0.08 | 0.06 | 0.07 | 0.09 | 0.13 | 0.10 | 0.12 | 0.21 | 47.00 | 25.37 | 51.42 | 65.39 | 60.71 | |
Operating Profit | -0.08 | -0.06 | -0.07 | -0.09 | -0.13 | -0.10 | -0.12 | -0.21 | 2.77 | -4.66 | 6.24 | 8.72 | 7.11 |
OPM % | 5.57% | -22.50% | 10.82% | 11.77% | 10.48% | ||||||||
0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.20 | -3.85 | 0.22 | 0.14 | 0.33 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.15 | 1.97 | 1.89 | 2.85 | 3.60 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.40 | 0.34 | 0.93 | 1.58 |
Profit before tax | -0.08 | -0.01 | -0.07 | -0.10 | -0.13 | -0.10 | -0.12 | -0.05 | 0.81 | -10.88 | 4.23 | 5.08 | 2.26 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.39% | |
-0.08 | -0.01 | -0.07 | -0.10 | -0.13 | -0.10 | -0.12 | -0.05 | 0.81 | -10.89 | 4.23 | 5.06 | 2.26 | |
EPS in Rs | -0.22 | -0.03 | -0.19 | -0.27 | -0.36 | -0.27 | -0.33 | -0.14 | 2.22 | -3.18 | 1.24 | 1.48 | 0.66 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 14% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 58% |
5 Years: | 117% |
3 Years: | 90% |
TTM: | -60% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 59% |
3 Years: | 109% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 4% |
Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 3.64 | 34.23 | 34.23 | 34.23 | 43.48 |
Reserves | -0.21 | -0.22 | -0.29 | -0.39 | -0.52 | -4.12 | -4.25 | -4.30 | 27.19 | -14.28 | -10.05 | 6.13 | 8.79 |
Preference Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.25 | |
0.00 | 0.13 | 0.15 | 0.26 | 0.40 | 0.48 | 0.60 | 0.64 | 13.74 | 15.43 | 16.73 | 44.24 | 71.15 | |
0.13 | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 | 0.02 | 0.03 | 6.91 | 4.47 | 8.53 | 15.70 | 6.85 | |
Total Liabilities | 3.56 | 3.55 | 3.51 | 3.53 | 3.53 | 0.00 | 0.01 | 0.01 | 51.48 | 39.85 | 49.44 | 100.30 | 130.27 |
3.51 | 3.51 | 3.51 | 3.50 | 3.50 | 0.00 | 0.00 | 0.00 | 17.36 | 15.11 | 15.33 | 23.81 | 23.59 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.59 | 13.72 | 13.22 | 12.72 | 12.72 |
Investments | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.19 | 0.19 | 7.99 | 7.99 |
0.00 | 0.04 | 0.00 | 0.03 | 0.03 | 0.00 | 0.01 | 0.01 | 20.52 | 10.83 | 20.70 | 55.78 | 85.97 | |
Total Assets | 3.56 | 3.55 | 3.51 | 3.53 | 3.53 | 0.00 | 0.01 | 0.01 | 51.48 | 39.85 | 49.44 | 100.30 | 130.27 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.07 | -0.06 | -0.09 | -0.13 | -0.10 | -0.12 | -0.21 | 5.96 | 0.52 | 3.47 | 8.33 | |
0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.67 | -0.56 | 0.59 | -14.09 | |
0.00 | -0.13 | 0.02 | 0.12 | 0.14 | 0.08 | 0.13 | 0.20 | -1.28 | -0.73 | -3.23 | 4.93 | |
Net Cash Flow | 0.00 | 0.05 | -0.04 | 0.02 | 0.01 | -0.03 | 0.01 | 0.00 | 1.01 | -0.78 | 0.82 | -0.83 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51.63 | 84.07 | 81.53 | 79.93 | ||||||||
Inventory Days | 56.98 | 25.01 | 12.59 | 16.36 | ||||||||
Days Payable | 70.35 | 79.21 | 59.29 | 13.72 | ||||||||
Cash Conversion Cycle | 38.26 | 29.87 | 34.84 | 82.57 | ||||||||
Working Capital Days | 80.08 | 69.79 | 50.83 | 208.23 | ||||||||
ROCE % | -2.30% | -1.72% | -1.99% | -2.85% | -3.70% | -5.68% | 8.80% | -12.01% | 16.04% | 12.51% |
Documents
Announcements
- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2024 12 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - DP) Regulations 2018, for the quarter ended March 31, 2024.
- Closure of Trading Window 1 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 29 Mar
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
28 Mar - Company had vide an announcement dated 10/01/2024, intimated the resignation of Mr. Rajesh Kumar Sundarray (ACS membership no.A66744), from the position of Company Secretary and …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure